Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 539-547
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.539
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.539
Ref. | Disease | Study | Patients (n) | HBV status (n) | Pre-emptive therapy | HBV reactivations (n) |
Cheng et al[58] | Autoimmune diseases | Case report | 2 | CHB (1) RS (1) | No | 2 |
Nakanishi et al[57] | Polymyositis | Case report | 1 | CHB | No | 1 |
Zanati et al[59] | Mixed connective tissue disease | Case report | 1 | CHB | No | 1 |
Bae et al[60] | Rheumatoid arthritis | Case report | 1 | CHB | No | 1 |
Li et al[61] | Idiopathic nephrotic syndrome | Prospective | 41 | CHB (41) | No | 21 |
Yang et al[62] | Connective tissue disease | Retrospective | 98 | CHB (21) Not applied (77) | No | 4 |
Loras et al[39] | IBD | Retrospective | 25 | CHB | No | 6 |
- Citation: López-Serrano P, Briongos ELF, Alonso EC, Pérez-Calle JL, Rodríguez CF. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy. World J Hepatol 2015; 7(3): 539-547
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/539.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.539